Paris, France

Solange G D'Ambrieres

This inventor holds 6 USPTO granted patents. Top assignee: Roussel Uclaf. Active years: 1994-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Solange G D'Ambrieres. Retrieved from https://idiyas.com/inventor/solange-g-d-ambrieres

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 85(Granted Patents)


Company Filing History:


Years Active: 1994-1997

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Solange G D'Ambrieres: A Pioneer in Antibiotic Innovation

Introduction

Solange G D'Ambrieres is a notable inventor based in Paris, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotic compounds. With a total of six patents to her name, her work has had a profound impact on medical science.

Latest Patents

Among her latest patents are innovative erythromycin compounds. These compounds are characterized by their antibiotic activity and are represented by a specific formula. Additionally, she has developed cephalosporins, which include a syn isomer in either (R) or (S) form. These compounds possess antibacterial properties and are crucial in the fight against bacterial infections.

Career Highlights

Solange works at Roussel Uclaf, a company known for its commitment to pharmaceutical advancements. Her career is marked by her dedication to research and development in the field of antibiotics. She has played a vital role in creating effective treatments that address various bacterial infections.

Collaborations

Throughout her career, Solange has collaborated with esteemed colleagues such as Jean-Francois Chantot and Jozsef Aszodi. These partnerships have fostered an environment of innovation and have contributed to the success of her projects.

Conclusion

Solange G D'Ambrieres stands out as a leading figure in antibiotic research and development. Her contributions continue to influence the pharmaceutical industry and improve healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…